Doctor profile · Federal record
Dr. Arnold Toback, M.D.
Dermatology Physician (CMS: Dermatology) · New York, NY
- NPI 1194749291
- Accepts Medicare
- MIPS 80.5 / 100 · 2023
- 46 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
2 E 69Th St
New York, NY 100214906
(212) 737-1440
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1980 — 46 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- New York #155647
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1194749291. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
9,199
Distinct HCPCS
10
Medicare allowed
$201,184
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 6,600 | 27 | $2 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 719 | 125 | $8 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 712 | 399 | $103 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 309 | 216 | $65 | |
17000 |
Destruction of precancer skin growth, 1 growth | 245 | 177 | $70 | |
11102 |
Biopsy of related skin growth, first growth | 236 | 178 | $117 | |
11103 |
Biopsy of related skin growth, each additional growth | 89 | 51 | $60 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 44 | 29 | $146 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 39 | 25 | $1 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 38 | 38 | $130 |
In context: peer comparison
Among 139 peers in this city , average services per provider: 182. This provider delivers 51× the peer median.Open Payments
Industry payments received
All-time total
$1,506
Transactions
79
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 26 | $426.32 | |
| Lilly USA, LLC | 11 | $237.99 | |
| PFIZER INC. | 9 | $160.30 | |
| UCB, Inc. | 10 | $157.25 | |
| GENZYME CORPORATION | 5 | $131.97 | |
| Novartis Pharmaceuticals Corporation | 4 | $85.96 | |
| Verrica Pharmaceuticals Inc. | 3 | $68.37 | |
| Amgen Inc. | 2 | $50.84 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $44.28 | |
| Janssen Biotech, Inc. | 2 | $42.18 | |
| Incyte Corporation | 2 | $37.22 | |
| Arcutis Biotherapeutics, Inc. | 1 | $24.52 | |
| Biofrontera Inc. | 1 | $19.77 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $19.31 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
320
Patients
169
Total drug cost
$13,067
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 54 | 38 | $3,469 |
| Mupirocin | Generic | 51 | 44 | $470 |
| Ketoconazole | Generic | 37 | 20 | $538 |
| Tretinoin | Generic | 33 | 0 | $2,528 |
| Desonide | Generic | 27 | 20 | $966 |
| Fluorouracil | Generic | 17 | 13 | $1,375 |
| Minoxidil | Generic | 17 | 0 | $317 |
| Triamcinolone Acetonide | Generic | 17 | 11 | $188 |
| Ciclopirox (Ciclopirox Olamine) | Brand | 16 | 11 | $623 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 15 | 0 | $1,178 |
Hospital affiliations
Frequently asked questions
What is Dr. Arnold Toback's medical specialty?
Dr. Arnold Toback practices Dermatology Physician in New York, NY.
Where does Dr. Arnold Toback practice?
Dr. Arnold Toback practices at 2 E 69Th St, New York, NY 100214906. Office phone: 2127371440.
What is Dr. Arnold Toback's NPI?
Dr. Arnold Toback's National Provider Identifier (NPI) is 1194749291, issued by NPPES.
Does Dr. Arnold Toback accept Medicare assignment?
Yes. Dr. Arnold Toback accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Arnold Toback commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.